Research, publications & scientific advancement.
Generating and sharing clinically relevant evidence to improve standards of metabolic care.
Why research matters
Much of the evidence behind metabolic care comes from populations different from those our members treat. Local, real-world evidence helps clinicians understand how diseases present and how treatments perform in their own settings.
IMACH aims to encourage collaborative research initiatives and the dissemination of clinically relevant scientific evidence, with a focus on questions that matter in everyday practice.
Areas of engagement
Multicentre collaborations
Connecting clinicians and institutions to answer questions together.
Real-world evidence
Studying how treatments perform in routine practice.
Registries & observational studies
Long-term data on disease patterns and outcomes.
Consensus & position statements
Expert agreement where evidence is incomplete.
Publications & reviews
Narrative and systematic reviews on priority topics.
Practice surveys
Understanding how clinicians actually manage patients.
Methodology training
Research design, statistics and evidence appraisal.
Technology assessment
Evaluating emerging therapies, diagnostics and digital tools.
Research priorities
Priority questions are drawn from the IMACH therapy areas, for example:
- Prevalence of undiagnosed complications in diabetes
- Use of organ-protective therapies in routine practice
- MASLD fibrosis screening in primary care
- Postpartum follow-up after gestational diabetes
- Obesity treatment outcomes and weight maintenance
- Lipid target attainment in high-risk patients
- Sleep apnoea in metabolic clinics
- Multimorbidity patterns in older adults
How to get involved
Propose
Submit a research idea or collaboration proposal.
Connect
IMACH links you with interested investigators and sites.
Develop
Support with protocol design and methodology.
Share
Present and publish findings through IMACH platforms.
Ethics & integrity
IMACH-supported research is expected to follow applicable ethics approvals, informed consent, data-protection requirements and good clinical practice, with transparent disclosure of funding and conflicts of interest.
Collaborate on research.
Members can join research networks and propose studies.